HomeNewsBusinessEconomyIIP: High industrial output figures may not reflect real growth due to low-base effect from 2020 lockdown

IIP: High industrial output figures may not reflect real growth due to low-base effect from 2020 lockdown

While March IIP figures, and those over the coming months, could be encouraging only due to low-base effect, CPI inflation is not expected to stay in sub-5 per cent territory either, analysts say

May 13, 2021 / 20:48 IST
Story continues below Advertisement

After more than a year of low growth, contraction and slight increases, India's industrial output has shot up in March by rising a stellar 22.4 percent. However, the assuring figures remain just on paper. Now, economists warn that while growth figures may seem massive going forward, they will not be an accurate depiction of the country's industrial state given the extreme low base effect.

Measured by the Index of Industrial Production (IIP), industrial output had suddenly risen in March, after contracting by 3.4 and 0.87 percent in the previous two months of February and January. The IIP is calculated on a year-on-year basis, and the latest percentage rise in industrial output for March, 2021 is based on how output has moved relative to March, 2020. Since that had been the exact month when the nationwide lockdown began and industries shuttered down, the output in March, last year was historically low.

Story continues below Advertisement

Economists say the latest double digit growth figures mean little given the are being calculated on that low production base of March 2020, which had witnessed nearly 1/3rd less working days due to country wide lockdown.

"Given the low base of the lockdown, we believe it's more meaningful to compare the industrial performance in March 2021 with March 2019, which reveals a mild albeit sobering contraction of 0.5 percent," Aditi Nayar, Chief Economist at ICRA, said.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show